CanSense

CanSense is an innovative startup in the biotechnology and healthcare industries, with a focus on revolutionizing blood testing for cancer. Founded in 2018 and headquartered in the United Kingdom, CanSense leverages cutting-edge data analytics and machine learning to enhance the performance of its blood test, which is designed to triage patients at high risk of cancer. The company recently secured a significant boost with a £1.50M Seed Round investment on 08 March 2023, with backing from notable investors including the Development Bank of Wales, Mercia, and Nonacus. CanSense's innovative approach to cancer detection, coupled with strong financial support, positions it for potential growth and impact in the critical area of cancer diagnostics.